Form 4/A for OMDA Omada Health, Inc.
Accepted 2026-07-08 20:15:16 ET · period of report 2026-06-22 · accession 0001610717-26-000328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAT | 2026-07-08 20:15 | 2026-06-22 | OMDA | Cook Steven L. | CFO | M - OptEx | $7.81 | +17.9K | 205.2K | +10% | +$140.1K |
| DAT | 2026-07-08 20:15 | 2026-06-22 | OMDA | Cook Steven L. | CFO | S - Sale+OE | $18.13 | -17.9K | 187.2K | -9% | -$325.4K |
| DMAT | 2026-07-08 20:15 | 2026-06-22 | OMDA | Cook Steven L. | CFO | M - OptEx | $0.00 | -17.9K | 22.2K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | M | A | 6,839 | $8.01 | 194,048 | D | — | — | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. |
| 2 | Common | Common Stock | 2026-06-22 | M | A | 11,111 | $7.68 | 205,159 | D | — | — | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. |
| 3 | Common | Common Stock | 2026-06-22 | S | D | 17,950 | $18.13 | 187,209 | D | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-06-22 | M | D | 6,839 | $0.00 | 43,161 | D | $8.01 · — to 2034-02-08 | 6,839 Common Stock | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. (F4) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-06-22 | M | D | 11,111 | $0.00 | 22,222 | D | $7.68 · — to 2035-01-27 | 11,111 Common Stock | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. (F5) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |